SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-21-030446
Filing Date
2021-12-03
Accepted
2021-12-03 16:32:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 def1a4a.htm DEFA14A 58297
2 ex99-1_001.jpg GRAPHIC 178926
3 ex99-1_002.jpg GRAPHIC 353688
4 ex99-1_003.jpg GRAPHIC 483613
5 ex99-1_004.jpg GRAPHIC 352416
6 ex99-1_005.jpg GRAPHIC 357709
7 ex99-1_006.jpg GRAPHIC 386210
8 ex99-1_007.jpg GRAPHIC 303386
9 ex99-1_008.jpg GRAPHIC 403686
  Complete submission text file 0001493152-21-030446.txt   3943315
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36268 | Film No.: 211470480
SIC: 2835 In Vitro & In Vivo Diagnostic Substances